Lupin Limited (IN:LUPIN)

:LUPIN

LUPIN

Lupin Limited

RESEARCH TOOLSreports

Want to see IN:LUPIN full AI Analyst Report?

Lupin Limited (LUPIN) Price & Analysis

13 Followers

LUPIN Stock Chart & Stats

₹1938.85

-₹105.50(-4.47%)

At close: Jan 08 4:00 PM EST

₹1938.85

-₹105.50(-4.47%)

Day’s Range― - ―

52-Week Range₹1,838.65 - ₹2,381.05

Previous CloseN/A

Volume1.35M

Average Volume (3M)25.39K

Market Cap

₹1.05T

Enterprise Value₹1.08T

Total Cash (Recent Filing)₹62.82B

Total Debt (Recent Filing)₹62.17B

Price to Earnings (P/E)20.5

Beta0.58

Next Earnings

May 07, 2026

EPS Estimate

26.5

Next Dividend Ex-DateN/A

Dividend Yield0.57%

Share Statistics

EPS (TTM)33.40

Shares Outstanding457,179,100

10 Day Avg. Volume23,417

30 Day Avg. Volume25,387

Financial Highlights & Ratios

PEG Ratio0.38

Price to Book (P/B)5.20

Price to Sales (P/S)3.94

P/FCF Ratio67.94

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹2,460.00

Price Target Upside26.88% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)99.33

Revenue Forecast (FY)₹286.61B

Bulls Say, Bears Say

Bulls Say

High Profitability MarginsLupin’s elevated gross and operating margins indicate durable cost advantages and efficient operations across formulations and APIs. Sustained margins support reinvestment in R&D and specialty launches, provide buffer against price cycles, and enable long-term profitability resilience.

Consistent Revenue GrowthSteady top-line growth reflects successful product launches and geographic diversification across branded India, international generics and APIs. Durable revenue expansion helps realize scale economies, funds pipeline development, and reduces reliance on any single market over months.

Solid Balance Sheet And Capital EfficiencyModerate leverage and a strong equity base provide financial flexibility to invest in complex generics, absorb regulatory setbacks, or pursue M&A. High ROE signals effective capital deployment, supporting sustainable returns and resilience over a multi-month horizon.

Bears Say

Weak Free Cash Flow ConversionA sharp decline in free cash flow growth and low FCF/net income indicate weaker cash conversion, potentially from working capital or capex. Persistent FCF weakness can constrain capex, debt servicing and investments in specialty programs, reducing strategic optionality.

Exposure To Generics Pricing PressureHeavy reliance on off‑patent generics makes revenue and margins sensitive to price erosion, tender outcomes and competitors' entries. Structural commoditization in large generics markets can compress margins and make mid‑term revenue outcomes more volatile.

Regulatory And Litigation RisksEarnings and launch timelines depend on inspections, approvals and patent rulings. Regulatory setbacks, compliance issues or unfavorable litigation can delay launches, interrupt supply or force remediation—risks that materially affect revenue and operations over months to years.

Lupin Limited News

Lupin Schedules Q4 FY26 Earnings Call for May 8

Lupin Limited ( ($IN:LUPIN) ) has provided an update. Lupin Limited has notified the Indian stock exchanges that...

6d ago

LUPIN

Lupin launches generic Xigduo XR in U.S. diabetes market

The latest update is out from Lupin Limited ( ($IN:LUPIN) ). Lupin Limited has launched Dapagliflozin and Metformin...

7d ago

LUPIN

Lupin Gets Three Observations After U.S. FDA Audit of Somerset Plant

The latest update is out from Lupin Limited ( ($IN:LUPIN) ). Lupin Limited has reported that the U.S....

11d ago

LUPIN

Lupin’s U.S. Arm Settles Humana Antitrust Claim for $30 Million

The latest announcement is out from Lupin Limited ( ($IN:LUPIN) ). Lupin’s U.S. subsidiary, Lupin Pharmaceuticals, Inc., has...

12d ago

LUPIN

Lupin Wins U.S. FDA Nod for Generic Dapagliflozin Tablets

Lupin Limited ( ($IN:LUPIN) ) has issued an announcement. Lupin Limited has secured U.S. Food and Drug Administration...

22d ago

LUPIN

Lupin Wins Tentative U.S. FDA Nod for Generic Pitolisant Tablets

The latest announcement is out from Lupin Limited ( ($IN:LUPIN) ). Lupin Limited has secured tentative approval from...

1M ago

LUPIN

Lupin Receives Two FDA Observations After Ankleshwar Plant Inspection

Lupin Limited ( ($IN:LUPIN) ) has issued an update. Lupin Limited said the U.S. Food and Drug Administration...

2M ago

LUPIN

Lupin Says GST Department Inspection Concludes With No Financial Impact

Lupin Limited ( ($IN:LUPIN) ) has shared an update. Lupin Limited reported that the Maharashtra Goods & Service...

2M ago

LUPIN

Lupin Wins Positive U.S. FDA Inspection Outcome for Goa Plant

Lupin Limited ( ($IN:LUPIN) ) has shared an announcement. Global drugmaker Lupin Limited has received an Establishment Inspection...

2M ago

LUPIN

Lupin CEO Vinita Gupta Named CNBC Changemaker as U.S. Expansion Gains Momentum

Lupin Limited ( ($IN:LUPIN) ) has issued an announcement. Lupin Limited announced that its CEO, Vinita Gupta, has...

2M ago

LUPIN

LUPIN FAQ

What was Lupin Limited’s price range in the past 12 months?

Lupin Limited lowest stock price was ₹1838.65 and its highest was ₹2381.05 in the past 12 months.

What is Lupin Limited’s market cap?

Lupin Limited’s market cap is ₹1.05T.

When is Lupin Limited’s upcoming earnings report date?

Lupin Limited’s upcoming earnings report date is May 07, 2026 which is in 8 days.

How were Lupin Limited’s earnings last quarter?

Lupin Limited released its earnings results on Feb 12, 2026. The company reported ₹33.4 earnings per share for the quarter, beating the consensus estimate of ₹27.566 by ₹5.834.

Is Lupin Limited overvalued?

According to Wall Street analysts Lupin Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Lupin Limited pay dividends?

Lupin Limited pays a Annually dividend of ₹12 which represents an annual dividend yield of 0.57%. See more information on Lupin Limited dividends here

What is Lupin Limited’s EPS estimate?

Lupin Limited’s EPS estimate is 26.5.

How many shares outstanding does Lupin Limited have?

Lupin Limited has 457,179,100 shares outstanding.

What happened to Lupin Limited’s price movement after its last earnings report?

Lupin Limited reported an EPS of ₹33.4 in its last earnings report, beating expectations of ₹27.566. Following the earnings report the stock price went up 0.066%.

Which hedge fund is a major shareholder of Lupin Limited?

Currently, no hedge funds are holding shares in IN:LUPIN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Lupin Limited

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Lupin Limited (LUPIN) Earnings & Revenues

Historic Earnings Reports

LUPIN Stock 12 Month Forecast

Average Price Target

₹2,460.00

▲(26.88% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1864":"₹1,864","2461":"₹2,461","2013.25":"₹2,013.3","2162.5":"₹2,162.5","2311.75":"₹2,311.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹2.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹2.46K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2460,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹2.46K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1864,2013.25,2162.5,2311.75,2461],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2273.6,2287.9384615384615,2302.276923076923,2316.6153846153848,2330.953846153846,2345.2923076923075,2359.630769230769,2373.9692307692308,2388.3076923076924,2402.646153846154,2416.9846153846156,2431.3230769230768,2445.6615384615384,{"y":2460,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2273.6,2287.9384615384615,2302.276923076923,2316.6153846153848,2330.953846153846,2345.2923076923075,2359.630769230769,2373.9692307692308,2388.3076923076924,2402.646153846154,2416.9846153846156,2431.3230769230768,2445.6615384615384,{"y":2460,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2273.6,2287.9384615384615,2302.276923076923,2316.6153846153848,2330.953846153846,2345.2923076923075,2359.630769230769,2373.9692307692308,2388.3076923076924,2402.646153846154,2416.9846153846156,2431.3230769230768,2445.6615384615384,{"y":2460,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1944.32,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2081.72,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1947.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1949.19,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1865.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1898.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1981.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1964.25,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2086.35,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2103.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2128.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2311.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2273.6,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >